188 related articles for article (PubMed ID: 3929314)
1. Tyramine pressor sensitivity changes during deprenyl treatment.
Sunderland T; Mueller EA; Cohen RM; Jimerson DC; Pickar D; Murphy DL
Psychopharmacology (Berl); 1985; 86(4):432-7. PubMed ID: 3929314
[TBL] [Abstract][Full Text] [Related]
2. Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.
Pickar D; Cohen RM; Jimerson DC; Lake CR; Murphy DL
Psychopharmacology (Berl); 1981; 74(1):8-12. PubMed ID: 6791210
[TBL] [Abstract][Full Text] [Related]
3. Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.
Prasad A; Glover V; Goodwin BL; Sandler M; Signy M; Smith SE
Psychopharmacology (Berl); 1988; 95(4):540-3. PubMed ID: 3145523
[TBL] [Abstract][Full Text] [Related]
4. Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.
Pickar D; Cohen RM; Jimerson DC; Murphy DL
Psychopharmacology (Berl); 1981; 74(1):4-7. PubMed ID: 6791202
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.
Sandler M; Glover V; Ashford A; Esmail A
J Neural Transm; 1980; 48(4):241-7. PubMed ID: 6775051
[TBL] [Abstract][Full Text] [Related]
6. Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
Schulz R; Antonin KH; Hoffmann E; Jedrychowski M; Nilsson E; Schick C; Bieck PR
Clin Pharmacol Ther; 1989 Nov; 46(5):528-36. PubMed ID: 2510962
[TBL] [Abstract][Full Text] [Related]
7. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
Zimmer R
Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Sunderland T; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
Psychopharmacology (Berl); 1987; 91(3):293-6. PubMed ID: 2436247
[TBL] [Abstract][Full Text] [Related]
9. Absence of "cheese effect" during deprenyl therapy: some recent studies.
Sandler M; Glover V; Ashford A; Stern GM
J Neural Transm; 1978; 43(3-4):209-15. PubMed ID: 745013
[TBL] [Abstract][Full Text] [Related]
10. Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
Mendis N; Pare CM; Sandler M; Glover V; Stern GM
Psychopharmacology (Berl); 1981; 73(1):87-90. PubMed ID: 6785797
[TBL] [Abstract][Full Text] [Related]
11. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
Abdo-Rubo A
Acta Physiol Hung; 1990; 75(4):321-36. PubMed ID: 2127505
[TBL] [Abstract][Full Text] [Related]
12. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
Murphy DL; Karoum F; Pickar D; Cohen RM; Lipper S; Mellow AM; Tariot PN; Sunderland T
J Neural Transm Suppl; 1998; 52():39-48. PubMed ID: 9564606
[TBL] [Abstract][Full Text] [Related]
13. Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.
Barrett JS; Hochadel TJ; Morales RJ; Rohatagi S; DeWitt KE; Watson SK; Darnow J; Azzaro AJ; DiSanto AR
J Clin Pharmacol; 1997 Mar; 37(3):238-47. PubMed ID: 9089426
[TBL] [Abstract][Full Text] [Related]
14. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
[TBL] [Abstract][Full Text] [Related]
15. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
Kerecsen L; Bunag RD
J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
17. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
Severina IS
Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
[TBL] [Abstract][Full Text] [Related]
18. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Glover V; Pycock CJ; Sandler M
Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
[TBL] [Abstract][Full Text] [Related]
19. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
20. A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.
Clarke A; Johnson ES; Mallard N; Corn TH; Johnston A; Boyce M; Warrington S; MacMahon DG
J Neural Transm (Vienna); 2003 Nov; 110(11):1257-71. PubMed ID: 14628190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
